CHF appreciates the opportunity to provide feedback to the Therapeutic Goods Administration (TGA) review of the regulation of certain self-testing IVDs in Australia. Our response to the consultation includes consideration and input from our members. 

We are of the view that consumers should be empowered in their healthcare and not given paternalistic “protection” by denying access to self-testing kits. We believe that consumers should receive support so they can confidently and appropriately use the self-testing kits and we don't support prohibiting products “for the consumers own good.” CHF advocates that policy should support the education and empowerment for consumers to improve their own health literacy and be actively involved in their own healthcare.